Docetaxel induces moderate ovarian toxicity in mice, primarily affecting granulosa cells of early growing follicles

Molecular Human Reproduction

Volumn 20, Issue 10, 2014, Pages 948-959

  Lopes, Federica ^a   Smith, Rowena ^a   Anderson, Richard A ^a   Spears, Norah ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Apoptosis; Docetaxel; Mouse; Ovarian follicles; Thyroid hormone

Indexed keywords

CASPASE 3; CASPASE 8; CYTOCHROME C; DOCETAXEL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; LIOTHYRONINE; TAXOID; TUBULIN MODULATOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GRANULOSA CELL; IN VITRO STUDY; MITOCHONDRION; MOUSE; NEWBORN; NONHUMAN; OOCYTE; OVARIAN TOXICITY; OVARY DISEASE; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; PROTEIN EXPRESSION; SOMATIC CELL; STROMA CELL; TOXICITY; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; METABOLISM; PATHOLOGY;

MUS;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 8; CELL PROLIFERATION; CELLS, CULTURED; CYTOCHROMES C; FEMALE; GRANULOSA CELLS; MICE; MICE, INBRED C57BL; MITOCHONDRIA; OOCYTES; POLY(ADP-RIBOSE) POLYMERASES; TAXOIDS; TRIIODOTHYRONINE; TUBULIN MODULATORS;

EID: 84917732099     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gau057     Document Type: Article

References (44)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat Rec 1946;94:239-247.
2. Anderson RA, Themmen APN, Al Qahtani A, Groome NP, Cameron DA. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod 2006;21:2583-2592.
3. Baker SD, Zhao M, Lee CKK, Verweij J, Zabelina Y, Brahmer JR,Wolff AC, Sparreboom A, Carducci MA. Comparative pharmacokinetics of weekly and every-three-weeks docetaxel. Clin Cancer Res 2004;10:1976-1983.
4. Berliere M, Dalenc F, Malingret N, Vindevogel A, Piette P, Roche H, Donnez J, Symann M, Kerger J, Machiels JP. Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without Docetaxel. BMC Cancer 2008;8:56.
5. Brunsvig PF, Andersen A, Aamdal S, Kristensen V, Olsen H. Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy. BMC Cancer 2007;7:197.
6. Fabbri F, Carloni S, Brigliadori G, Zoli W, Lapalombella R, Marini M. Sequential events of apoptosis involving docetaxel, a microtubuleinterfering agent: a cytometric study. BMC Cell Biol 2006;7:6.
7. Gligorov J, Lotz JP. Preclinical pharmacology of the taxanes: implications of the differences. Oncologist 2004;9(Suppl 2):3-8.
8. Gonfloni S, DiTella L, Caldarola S, Cannata SM, Klinger FG, Di Bartolomeo C, Mattei M, Candi E, De Felice M, Melino G et al. Inhibition of the c-Abl-Tap63 pathway protects mouse oocytes from chemotherapyinduced death. Nat Med 2009;15:1179-1185.
9. Gucer F, Balkanli-Kaplan P, Doganay L, Yuce MA, Demiralay E, Sayin NC, Yarsim T. Effect of paclitaxel on primordial follicular reserve in mice. Fertil Steril 2001;76:628-629.
10. Han HS, Ro J, Lee KS, Nam BH, Seo JA, Lee DH, Lee H, Lee ES, Kang HS, Kim SW. Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer. Breast Cancer Res Treat 2009;115:335-342.
11. Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, Wolf I, Kanety H, Sredni B, Meirow D. Cyclophosphamide triggers follicle activation and 'burnout'; AS101 prevents follicle loss and preserves fertility. Sci Transl Med 2013;5:185ra62.
12. Khan KH, Blanco-Codesido M, Molife LR. Cancer therapeutics: targeting the apoptotic pathway. Crit Rev Oncol Hematol 2014;90:200-219.
13. Liu Y, Pu Y, Zhang X. Role of the mitochondrial signalling pathway in murine coronavirus-induced oligodendrocyte apoptosis. J Virol 2006; 80:395-403.
14. Maiani E, Di Bartolomeo C, Klinger FG, Cannata SM, Bernardini S, Chateauvieux S, Mack F, De Felici M, Diederich M, Cesareni G et al. Reply to: Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib. Nat Med 2012;18:1172-1174.
15. Mailhes JB, Carabatos MJ, Young D, London SN, Bell M, Albertini DF. Taxol induced meiotic maturation delay, spindle defects, and aneuploidy in mouse oocytes and zygotes. Mutat Res 1999;423:79-90.
16. Manabe N, Goto Y, Matsuda-Minehata F, Inoue N, Maeda A, Sakamaki K, Miyano T. Regulation mechanism of selective atresia in porcine follicles: regulation of granulosa cell apoptosis during atresia. J Reprod Dev 2004; 50:493-514.
17. Martin M, Pienkowski T, Mackey J, Pawlicki M, Guastalla JP, Weaver C, Tomiak E, Al-Tweigeri T, Chap L, Juhos E et al. Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 2005;352:2302-2313.
18. McGee EA, Hsueh AJW. Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000;21:200-214.
19. Meirow D, Dor J, Kaufman B, Shrim A, Rabinovic J, Shiff E, Raanani H, Levron J, Fridman E. Cortical fibrosis and blood-vessel damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod 2007;22:1626-1633.
20. Meirow D, Biederman H, Anderosn RA, Wallace WHB. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol 2010;53:727-739.
21. Minisini AM, Menis J, Valent F, Andreetta C, Alessi B, Pascoletti G, Piga A, Fasola G, Puglisi F. Determinants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era. Anticancer Drugs 2009;20:503-507.
22. Morgan S, Anderson RA, Gourley C, Wallace WH, Spears N. How do chemotherapeutic agents damage the ovary? Hum Reprod Update 2012; 18:525-535.
23. Morgan S, Lopes F, Gourly C, Anderson RA, Spears N. Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protectiononly against cisplatin. PLoSOne 2013;8:e70117.
24. Morita Y, Perez GI, Paris F, Miranda SR, Ehleiter D, Haimovitz-Friedman A, Fuks Z, Reed JC, Schuchman EH, Kolesnick RN et al. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med 2000;6:1109-1114.
25. Nicosia SV, Matus-Ridley M, MeadowsAT. Gonadal effects of cancer therapy in girls. Cancer 1985;55:2364-2372.
26. Pérez-Fidalgo JA, Roselló S, Garciá-Garré E, Jordá E, Martín-Martorell P, Bermejo B, Chirivella I, Guzman C, Lluch A. Incidence of chemotherapy induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens. Breast Cancer Res Treat 2010;120:245-251.
27. Petrillo SK, Desmeules P, Troung TQ, Devine PJ. Detection ofDNAdamage in oocytes of small ovarian follicles following phosphoramide mustard exposure of cultured rodent ovaries in vitro. Toxicol Appl Pharmacol 2011;253:94-102.
28. Roness H, Gavish Z,CohenY, MeirowD. Ovarian follicle burnout: a universal phenomenon? Cell Cycle 2013;12:3245-3246.
29. Roti Roti EC, Leisman SK, Abbott DH, Salih SM. Acute doxorubicin insult in the mouse ovary is cell- and follicle-type dependent. PLos One 2012; 7:e42293.
30. Sai T, Matsuda F, Goto Y, Maeda A, Sugimoto M, Gao HM, Kabir AK, Li JY, Manabe N. Effect of RNA interference of BID and BAX mRNAs on apoptosis in granulosa cell-derivedKGNcells.JReprodDev2012;58:112-116.
31. Salih SM. Retrovirus-mediated multidrug resistance gene (MDR1) overexpression inhibits chemotherapy-induced toxicity of granulosa cells. Fertil Steril 2011;95:1390-1396.
32. Slaviero KA, Clarke SJ, McLachlan AJ, Blair EY, Rivory LP. Population pharmacokinetics of weekly docetaxel in patients with advanced cancer. Br J Clin Pharmacol 2004;57:44-53.
33. Stavreus-Evers A. Paracrine interaction of thyroid hormones and thyroid stimulation hormone in the female reproductive tract have an impact on female fertility. Front Endocrinol 2012;3:1-8.
34. Sterling K, Bellabarba D, Newman ES, Brenner MA. Determination of triiodo-thyronine concentration in human serum. J Clin Invest 1969; 48:1150-1158.
35. Subrata H, Basu A, Croce CM. Bcl2 is the guardian of microtubule integrity. Cancer Res 1997;57:229-233.
36. TarumiW, Suzuki N, Takahashi N, Kobayashi Y, Kiguchi K, Sato K, Ishizuka B. Ovarian toxicity of paclitaxel and effect on fertility in the rat. J Obstet Gynaecol Res 2009;35:414-420.
37. Thomson TC, Ftzpatrick KE, Johnson J. Intrinsic and extrinsic mechanism of oocyte loss. Mol Hum Reprod 2010;16:916-927.
38. Torino F, Barnabei A, De Vecchis L, Appetecchia M, Strigan L, Corsello SM. Recognizing menopause in women with amenorrhea induced by cytotoxic chemotherapy for endocrine-responsive early breast cancer. Endocr Relat Cancer 2012;19:R21-R33.
39. Verga Falzacappa C, Mangialardo C, Patriarca V, Bucci B, Amendola D, Raffa S, Torrisi MR, Silvestrini G, Ballanti P, Moriggi G et al. Thyroid hormones induce cell proliferation and survival in ovarian granulosa cells COV434. J Cell Physiol 2009;221:242-253.
40. Verga Falzacappa C, Timperi E, Bucci B, Amendola D, Piergrossi P, D'Amico D, Santaguida MG, Centanni M, Misiti S. T(3) preserves ovarian granulosa cells from chemotherapy-induced apoptosis. J Endocrinol 2012;215:281-289.
41. Wallace HB, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One 2010;5:e8772.
42. Yucebilgin MS, Terek MC, Ozsaran A, Akercan F, Zerioglu O, Isik E, Erhan Y. Effect of chemotherapy on primordial follicular reserve in rat: An animal model of premature ovarian failure and infertility. Aust N Z J Obstet Gynaecol 2004;44:6-9.
43. Zhao XJ, Huang YH, Yu YC, Xin XY. GnRH antagonist cetrorelix inhibits mitochondria-dependent apoptosis triggered by chemotherapy in granulosa cells of rats. Gynecol Oncol 2010;118:69-75.
44. Zhou WB, Yin H, Liu XA, Zha XM, Chen L, Dai JC, Tao AD, Chen L, Ma JJ, Ling LJ et al. Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients. BMC Cancer 2010;10:281.